HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

Curcumin-phosphatidylcholine

WITHDRAWN · NA · Tinnitus, Subjective

Study was not pursued after joint venture completed with Henry Ford Health.

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.